These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3179798)

  • 21. [Changes in lipoprotein composition and cardiovascular risk in subjects with normal plasma lipids].
    Pedro-Botet J; Rubiés-Prat J
    Rev Clin Esp; 1993 Jun; 193(1):1-2. PubMed ID: 8337452
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL
    J Am Coll Cardiol; 2008 Apr; 51(15):1512-24. PubMed ID: 18402913
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dietary fats and serum lipoproteins].
    Schwandt P
    Verh Dtsch Ges Inn Med; 1986; 92():595-600. PubMed ID: 3811560
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification and relative weight of cardiovascular risk factors.
    Hopkins PN; Williams RR
    Cardiol Clin; 1986 Feb; 4(1):3-31. PubMed ID: 3518932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diet-heart question: how good is the evidence?
    McNamara DJ
    ASDC J Dent Child; 1987; 54(5):349-52. PubMed ID: 3478362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet and cardiovascular disease: beyond cholesterol.
    Rivellese AA
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):395-8. PubMed ID: 16314224
    [No Abstract]   [Full Text] [Related]  

  • 27. Workshop on the impact of dietary cholesterol on plasma lipoproteins and atherogenesis.
    Grundy SM; Barrett-Connor E; Rudel LL; Miettinen T; Spector AA
    Arteriosclerosis; 1988; 8(1):95-101. PubMed ID: 3341995
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL; ;
    Diabetes Care; 2008 Apr; 31(4):811-22. PubMed ID: 18375431
    [No Abstract]   [Full Text] [Related]  

  • 29. The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins.
    Ordovas JM
    Proc Nutr Soc; 2004 Feb; 63(1):145-52. PubMed ID: 15070444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is..
    Sniderman AD
    Circulation; 2005 Nov; 112(22):3366-7. PubMed ID: 16316960
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A prevalence study on risk factors of cardiovascular disease during childhood].
    Feng N; Ye G; Shao L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Jan; 31(1):27-30. PubMed ID: 9812633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public policy and dietary recommendations to reduce population levels of blood cholesterol.
    Blackburn H
    Am J Prev Med; 1985; 1(5):3-11. PubMed ID: 3870917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not all eggs are created equal: the effect on health depends on the composition.
    Shapira N
    Can J Cardiol; 2011; 27(2):264.e5; 264.e7-8. PubMed ID: 21459288
    [No Abstract]   [Full Text] [Related]  

  • 35. Time to lower cholesterol.
    Cowling BD
    Med J Aust; 1989 Jan; 150(1):55. PubMed ID: 2909858
    [No Abstract]   [Full Text] [Related]  

  • 36. [What does the reduction of cholesterol benefit?].
    Ugeskr Laeger; 1990 Feb; 152(8):546-52. PubMed ID: 2309367
    [No Abstract]   [Full Text] [Related]  

  • 37. Dietary cholesterol, serum cholesterol, and risks of cardiovascular and noncardiovascular diseases.
    Stamler J; Greenland P; Van Horn L; Grundy SM
    Am J Clin Nutr; 1998 Mar; 67(3):488-92. PubMed ID: 9497196
    [No Abstract]   [Full Text] [Related]  

  • 38. The cholesterol controversy.
    Flynn MA
    J Med Soc N J; 1978 Jun; 75(6):484-5. PubMed ID: 275506
    [No Abstract]   [Full Text] [Related]  

  • 39. Emerging approaches to the examination of lipoproteins for cardio-metabolic risk stratification.
    Shokrani M
    MLO Med Lab Obs; 2014 Jan; 46(1):16-7. PubMed ID: 24527522
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol caveats.
    Ramírez EA
    Bol Asoc Med P R; 1989 Dec; 81(12):477-9. PubMed ID: 2619848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.